“circulate” clinical trial evaluating ctdna dynamics and clinical outcomes in colon cancer
Published 1 year ago • 137 plays • Length 8:04Download video MP4
Download video MP3
Similar videos
-
5:30
ctdna monitoring to assess clinical outcomes in mcrc treated with front-line chemotherapy
-
2:13
ongoing clinical trials on using ctdna results to guide gi cancer management
-
2:31
dynamic: ctdna guiding adjuvant chemotherapy in stage ii colon cancer
-
3:29
ctdna and cfdna : prognostic value in the neoadjuvant setting of colon cancer
-
25:08
is my treatment working? using ctdna to optimize the management of colorectal cancer
-
3:16
the utility of ctdna in colorectal cancer management
-
12:01
debate: is circulating tumor dna ready to guide adjuvant therapy in colon cancer? - yes
-
0:58
real-world monitoring of circulating tumor dna to predict cancer recurrence
-
15:23
2021 west oncology | gastrointestinal cancers | ctdna analysis in colorectal cancer
-
0:51
tracking clonal evolution in colorectal cancer using ctdna
-
4:31
cobra: ctdna to help decide which patients with colon cancer will benefit from adjuvant chemotherapy
-
3:41
circulate-us: investigating the use of ctdna to detect mrd
-
0:45
the emerging role of ctdna in cancer diagnostics
-
1:51
a positive ctdna test after adjuvant therapy: 2023 best of gi
-
46:16
the changing landscape of mrd testing for colorectal cancer: what's new in 2023?
-
0:48
ctdna in clinical practice for colon cancer
-
46:19
the use of ctdna for molecular residual disease assessment and immunotherapy monitoring in nsclc
-
1:25
moffitt medical minute - circulating tumor dna (ep. 9)
-
1:03:08
young-onset colorectal cancer center annual forum expert panel 2022